Monday, November 29, 2021
ADVT 
National

Pfizer says COVID-19 vaccine works in kids ages 5 to 11

Darpan News Desk The Canadian Press, 20 Sep, 2021 10:14 AM
  • Pfizer says COVID-19 vaccine works in kids ages 5 to 11

Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for youngsters.

The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older. But with kids now back in school and the extra-contagious delta variant causing a huge jump in pediatric infections, many parents are anxiously awaiting vaccinations for their younger children.

For elementary school-aged kids, Pfizer tested a much lower dose — a third of the amount that’s in each shot given now. Yet after their second dose, children ages 5 to 11 developed coronavirus-fighting antibody levels just as strong as teenagers and young adults getting the regular-strength shots, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press.

The kid dosage also proved safe, with similar or fewer temporary side effects — such as sore arms, fever or achiness — that teens experience, he said.

“I think we really hit the sweet spot,” said Gruber, who’s also a pediatrician.

Gruber said the companies aim to apply to the Food and Drug Administration by the end of the month for emergency use in this age group, followed shortly afterward with applications to European and British regulators.

Earlier this month , FDA chief Dr. Peter Marks told the AP that once Pfizer turns over its study results, his agency would evaluate the data “hopefully in a matter of weeks” to decide if the shots are safe and effective enough for younger kids.

An outside expert said scientists want to see more details but called the report encouraging.

"These topline results are very good news,” said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief. The level of immune response Pfizer reported “appears likely to be protective.”

Many Western countries so far have vaccinated no younger than age 12, awaiting evidence of what's the right dose and that it works safely. Cuba last week began immunizing children as young as 2 with its homegrown vaccines and Chinese regulators have cleared two of its brands down to age 3.

While kids are at lower risk of severe illness or death than older people, more than 5 million children in the U.S. have tested positive for COVID-19 since the pandemic began and at least 460 have died, according to the American Academy of Pediatrics. Cases in children have risen as the delta variant swept through the country.

“I feel a great sense of urgency” in making the vaccine available to children under 12, Gruber said. “There’s pent-up demand for parents to be able to have their children returned to a normal life.”

In New Jersey, 10-year-old Maya Huber asked why she couldn’t get vaccinated like her parents and both teen brothers have. Her mother, Dr. Nisha Gandhi, a critical care physician at Englewood Hospital, enrolled Maya in the Pfizer study at Rutgers University. But the family hasn’t eased up on their masking and other virus precautions until they learn if Maya received the real vaccine or a dummy shot.

Once she knows she’s protected, Maya’s first goal: “a huge sleepover with all my friends.”

Maya said it was exciting to be part of the study even though she was “super scared” about getting jabbed. But “after you get it, at least you feel like happy that you did it and relieved that it didn’t hurt," she told the AP.

Pfizer said it studied the lower dose in 2,268 kindergartners and elementary school-aged kids. The FDA required what is called an immune “bridging" study: evidence that the younger children developed antibody levels already proven to be protective in teens and adults. That's what Pfizer reported Monday in a press release, not a scientific publication. The study still is ongoing, and there haven't yet been enough COVID-19 cases to compare rates between the vaccinated and those given a placebo — something that might offer additional evidence.

The study isn’t large enough to detect any extremely rare side effects, such as the heart inflammation that sometimes occurs after the second dose, mostly in young men. The FDA’s Marks said the pediatric studies should be large enough to rule out any higher risk to young children. Pfizer’s Gruber said once the vaccine is authorized for younger children, they’ll be carefully monitored for rare risks just like everyone else.

A second U.S. vaccine maker, Moderna, also is studying its shots in elementary school-aged

MORE National ARTICLES

Canadians heading to the polls to choose next federal government

Canadians heading to the polls to choose next federal government

Elections Canada says almost 6.8 million people voted early, most of them at advanced polls over a week ago, and the rest through special ballots cast by mail or at Elections Canada offices.

Canadians heading to the polls to choose next federal government

Family of Chantel Moore says time to renew focus

Family of Chantel Moore says time to renew focus

A video statement issued yesterday by Moore's family and police Chief Del Manak follows the assault on Manak one day earlier. A woman poured liquid on the chief as he was an invited guest at a memorial for Moore outside the British Columbia legislature.

Family of Chantel Moore says time to renew focus

Surrey RCMP takes the magic out of illicit mushroom grow-op

Surrey RCMP takes the magic out of illicit mushroom grow-op

Once inside the residence, signs of illicit drug activity were noted and Surrey RCMP was called to assist. Frontline police officers attended and discovered what they believed to be a Psilocybin mushroom drug laboratory. A woman was arrested at the scene, and later released pending further investigation.

Surrey RCMP takes the magic out of illicit mushroom grow-op

UBC IMANT invests $120M in reduced carbon fund

UBC IMANT invests $120M in reduced carbon fund

The move follows $110 million in funding for a sustainable global opportunities strategy in March. UBC announced plans last year to divest the endowment of fossil fuel investments and a 45 per cent reduction of portfolio carbon emissions within 10 years.

UBC IMANT invests $120M in reduced carbon fund

Frontline officers seize fentanyl and firearms in Bear Creek neighborhood

Frontline officers seize fentanyl and firearms in Bear Creek neighborhood

Later the same day the officers executed the search warrant and located a number of items inside the residence including a 9mm Semi-Automatic Handgun; a fully automatic carbine rifle; ammunition; and 358 grams of suspected Fentanyl (approximately 3580 doses). The suspected fentanyl was packaged in a way that is consistent with street-level drug trafficking.

Frontline officers seize fentanyl and firearms in Bear Creek neighborhood

Trudeau links global detention initiative to China

Trudeau links global detention initiative to China

Prime Minister Justin Trudeau says Canada spearheaded an international declaration denouncing state-sponsored arbitrary detentions because of China's decision to imprison Michael Kovrig and Michael Spavor.

Trudeau links global detention initiative to China

PrevNext